Swedish study tracks Real-World use of breast cancer drug palbociclib
NCT ID NCT04654208
First seen Jan 05, 2026 · Last updated Apr 24, 2026 · Updated 15 times
Summary
This study looks at how patients with metastatic breast cancer in Sweden are actually using the drug palbociclib in everyday medical practice. Researchers will track 1,500 adults who have filled a prescription for palbociclib to see how long they stay on treatment and how well they do. The goal is to understand real-world treatment patterns and outcomes, not to test a new therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM OF BREAST are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pfizer Sweden
RECRUITINGSollentuna, Sweden
Conditions
Explore the condition pages connected to this study.